InvestorsHub Logo
Followers 0
Posts 179
Boards Moderated 0
Alias Born 09/06/2003

Re: None

Saturday, 12/09/2006 6:15:33 PM

Saturday, December 09, 2006 6:15:33 PM

Post# of 6489
The best part from the article

``It's very low risk given that the interest of the public is at stake,'' Matthew Osborne, an analyst at Lazard Capital Markets in New York, said in a phone interview. ``There would likely be a backlash from physicians if this drug were removed.''

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News